Show simple item record

dc.contributor.authorCruickshank, Margaret
dc.date.accessioned2019-02-27T00:04:46Z
dc.date.available2019-02-27T00:04:46Z
dc.date.issued2018-02-27
dc.identifier.citationCruickshank , M 2018 , ' Treatment or surveillance for CIN2? Women now have better data on regression and progression to help them decide ' , BMJ , vol. 360 , k771 , pp. 1-2 . https://doi.org/10.1136/bmj.k771en
dc.identifier.issn0959-8146
dc.identifier.otherPURE: 116554518
dc.identifier.otherPURE UUID: 902a20a2-621a-408f-b724-10d0ff3b0ed4
dc.identifier.otherPubMed: 29487080
dc.identifier.otherPubMed: 29487080
dc.identifier.otherScopus: 85042693794
dc.identifier.urihttp://hdl.handle.net/2164/11964
dc.descriptionAcknowledgments Jaimie Kavanagh reviewed and contributed to this editorial as a patient representative and volunteer for Jo’s Cervical Cancer Trust.en
dc.format.extent2en
dc.language.isoeng
dc.relation.ispartofBMJen
dc.rightsFor all Publisher commissioned articles, the right to post a version of the final published version of the Contribution, or any abstract of the final published Contribution on the Contributor(s)’s own and/or his/her institution’s website 12 months after publication. This article has been published in the BMJ, Cruickshank Maggie. Treatment or surveillance for CIN2? BMJ 2018; 360 :k771 and can also be viewed on the journal’s website at www.bmj.comen
dc.subjectEditorialen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleTreatment or surveillance for CIN2? : Women now have better data on regression and progression to help them decideen
dc.typeJournal itemen
dc.contributor.institutionUniversity of Aberdeen, Medical Educationen
dc.description.statusNon peer revieweden
dc.description.versionPublisher PDFen
dc.identifier.doihttps://doi.org/10.1136/bmj.k771
dc.date.embargoedUntil27-02-20


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record